| 000 | 01805 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517224844.0 | ||
| 264 | 0 | _c20191025 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1432-2072 | ||
| 024 | 7 |
_a10.1007/s00213-018-4962-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenturquia, Nadia | |
| 245 | 0 | 0 |
_aIs the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cMar 2019 |
||
| 300 |
_a891-901 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodioxoles _xadministration & dosage |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xadministration & dosage |
| 650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aIllicit Drugs _xadverse effects |
| 650 | 0 | 4 |
_aLocomotion _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethamphetamine _xadministration & dosage |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrrolidines _xadministration & dosage |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSynthetic Cathinone |
| 700 | 1 | _aChevillard, Lucie | |
| 700 | 1 | _aPoiré, Christophe | |
| 700 | 1 | _aRoussel, Olivier | |
| 700 | 1 | _aCohier, Camille | |
| 700 | 1 | _aDeclèves, Xavier | |
| 700 | 1 | _aLaplanche, Jean-Louis | |
| 700 | 1 | _aEtheve-Quelquejeu, Mélanie | |
| 700 | 1 | _aChen, Huixiong | |
| 700 | 1 | _aMégarbane, Bruno | |
| 773 | 0 |
_tPsychopharmacology _gvol. 236 _gno. 3 _gp. 891-901 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-018-4962-0 _zAvailable from publisher's website |
| 999 |
_c28597782 _d28597782 |
||